Monthly Archives: April 2012

How Buffett’s Cancer is Shaping National Dialogue on Science Friday Today

Posted on April 27, 2012 by Laura Newman

I will be on Science Friday today, sometime between 3:30 and 4:00 PM EST, with Ira Flatow. In New York, it will be on WNYC, on KQED in San Francisco at their time for the show (a three-hour time change). … Continue reading →

Posted in Prostate Cancer, Treatment decisions | Tagged , , , , , , , | 5 Comments

Top 10 Reasons Why Warren Buffett’s
Decision to Treat Prostate Cancer Bugs Me

Posted on April 19, 2012 by Laura Newman

On April 17th, 81-year-old Warren Buffett told investors that he had very early prostate cancer. The Washington Post headline read: “Warren Buffett Has Prostate Cancer that is ”Not Remotely Life Threatening.’” Within hours, news accounts said that the story unfolded … Continue reading →

Posted in Active Surveillance, men's health, Prostate Cancer, Treatment decisions | Tagged , , , , , , , , , | 22 Comments

PCORI Board Sets Listening/Webinar Mode
Only on Revised Research Priorities

Posted on April 13, 2012 by Laura Newman

It looks like The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors will hold a special teleconference/webinar in watch-only mode via teleconference/webinar on Wednesday, April 25, 2012. The Board will discuss and vote on PCORI’s revised National Priorities for Research … Continue reading →

Posted in patient-centered outcomes research, PCORI | Tagged , | Comments Off on PCORI Board Sets Listening/Webinar Mode
Only on Revised Research Priorities